FMP
AnPac Bio-Medical Science Co., Ltd.
ANPC
NASDAQ
Inactive Equity
AnPac Bio-Medical Science Co., Ltd., a biotechnology company, researches, develops, markets, and sells multi-cancer screening and detection tests using cancer differentiation analysis technology and device to corporations and life insurance companies in the People's Republic of China. It also offers physical checkup package services. The company was incorporated in 2010 and is headquartered in Lishui, the People's Republic of China.
4.3 USD
-0.14 (-3.26%)
About
ceo
Dr. Chris Chang Yu
sector
Healthcare
industry
Biotechnology
website
https://www.anpacbio.com
exchange
NASDAQ
Description
AnPac Bio-Medical Science Co., Ltd., a biotechnology company, researches, develops, markets, and sells multi-cancer screening and detection tests using cancer differentiation analysis technology and device to corporations and life insurance companies in the People's Republic of China. It also offers physical checkup package services. The company was incorporated in 2010 and is headquartered in Lishui, the People's Republic of China.
CIK
0001786511
ISIN
US03635R2067
CUSIP
03635R107
Address
801 Bixing Street
Phone
86 57 8205 1666
Country
CN
Employee
89
IPO Date
Jan 30, 2020
Summary
CIK
0001786511
Exchange
NASDAQ
Industry
Biotechnology
Sector
Healthcare
CUSIP
03635R107
ISIN
US03635R2067
Country
CN
Price
4.3
Beta
1.56
Volume Avg.
22.07k
Market Cap
26.97M
Shares
-
52-Week
2.6-11.99
DCF
0
ROE
-
ROA
-
Operating Margin
-
Debt/Equity
-
P/E
-0.38
P/B
-
Website
https://www.anpacbio.com
Historical Prices
We are unable to load the chart at this time.
Financial Statement
We are unable to load the chart at this time.
Earnings
We are unable to load the chart at this time.
Upgrades and Downgrades
We are unable to load this data!
People Also Watch
Financial Information
Financial Summary Real-Time Price
Financial Statements
Financial Quarter Statements
Ratios Analysis
Dupont Analysis
Free Cashflow
Operating Data
Balance Sheet Data
Financial Modelling
Discounted Cashflow Model
Discounted Cashflow Model Levered
Free Cashflow Build-Up
Terminal Value
Intrinsic Value
Weighted Average Cost of Capital
Market Information
Stock Value
Latest ANPC News
It looks like there's no news available.
